Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2019 May 28;7(8):2653–2660.e3. doi: 10.1016/j.jaip.2019.05.029

Table 2.

Serum cadmium and current wheeze in study participants, NHANES 2007-20121

Serum cadmium (μg/L)
Exposure Odds ratio (95% confidence interval)
All participants (n = 13,888)
  Quartile 1 (<0.22 μg/L) 1.00
  Quartile 2 (0.22 – 0.34 μg/L) 0.92 (0.75, 1.13)
  Quartile 3 (0.34 – 0.62 μg/L) 1.01 (0.82, 1.25)
  Quartile 4 (≥0.62 μg/L) 1.50 (1.20, 1.86) **
P for linear trend < 0.01
Never/former smokers (n = 10,742)
  Quartile 1 (<0.19 μg/L) 1.0
  Quartile 2 (0.19 – 0.28 μg/L) 0.83 (0.63, 1.08)
  Quartile 3 (0.28 – 0.43 μg/L) 1.10 (0.88, 1.37)
  Quartile 4 (≥0.43 μg/L) 1.19 (0.92, 1.54)
P for linear trend = 0.08
Current smokers (n = 3,146)
  Quartile 1 (<0.61 μg/L) 1.0
  Quartile 2 (0.61 – 0.99 μg/L) 1.91 (1.39, 2.63) **
  Quartile 3 (0.99 – 1.50 μg/L) 2.40 (1.70, 3.39) **
  Quartile 4 (≥1.50 μg/L) 2.84 (2.07, 3.90) **
P for linear trend < 0.01
1

All models were adjusted for age, gender, race/ethnicity, annual household income, BMI, family history of asthma, serum cotinine, and occupational exposure to mineral dusts or exhaust fumes. The model for all participants was additionally adjusted for smoking status.

2

* P< 0.05 and ** P< 0.01